Pro-Dex, Inc. (PDEX): Price and Financial Metrics

Pro-Dex, Inc. (PDEX): $17.61

-0.19 (-1.07%)

POWR Rating

Component Grades













PDEX Stock Summary

  • PDEX has a higher market value than only 15.47% of US stocks; more precisely, its current market capitalization is $63,049,365.
  • PDEX's went public 27.3 years ago, making it older than 74.77% of listed US stocks we're tracking.
  • In terms of volatility of its share price, PDEX is more volatile than 28.66% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to PRO DEX INC are CRMD, WISH, NSPR, BFLY, and AXDX.
  • Visit PDEX's SEC page to see the company's official filings. To visit the company's web site, go to

PDEX Valuation Summary

  • In comparison to the median Healthcare stock, PDEX's EV/EBIT ratio is 74.42% higher, now standing at 15.
  • PDEX's price/sales ratio has moved up 1.1 over the prior 243 months.

Below are key valuation metrics over time for PDEX.

Stock Date P/S P/B P/E EV/EBIT
PDEX 2022-11-25 1.5 2.6 16.6 15.0
PDEX 2022-11-23 1.5 2.6 16.5 14.9
PDEX 2022-11-22 1.4 2.5 16.1 14.6
PDEX 2022-11-21 1.4 2.5 16.0 14.5
PDEX 2022-11-18 1.4 2.4 15.4 14.1
PDEX 2022-11-17 1.4 2.4 15.4 14.1

PDEX Growth Metrics

    The 3 year price growth rate now stands at -13.67%.
  • Its 2 year net cashflow from operations growth rate is now at 103.11%.
  • Its 5 year revenue growth rate is now at 48.85%.
PDEX's revenue has moved up $20,675,000 over the prior 52 months.

The table below shows PDEX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 43.14 -0.656 3.868
2022-06-30 42.041 -0.847 3.855
2022-03-31 38.861 5.157 3.304
2021-12-31 41.335 1.056 4.837
2021-09-30 39.427 1.511 4.249
2021-06-30 38.029 -2.078 4.45

PDEX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PDEX has a Quality Grade of C, ranking ahead of 55.91% of graded US stocks.
  • PDEX's asset turnover comes in at 1.002 -- ranking 19th of 186 Medical Equipment stocks.
  • APEN, ZBH, and BDX are the stocks whose asset turnover ratios are most correlated with PDEX.

The table below shows PDEX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.002 0.357 0.150
2021-03-31 1.114 0.371 0.230
2020-12-31 1.136 0.372 0.237
2020-09-30 1.217 0.382 0.312
2020-06-30 1.201 0.377 0.316
2020-03-31 1.112 0.371 0.260

PDEX Price Target

For more insight on analysts targets of PDEX, see our PDEX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $39.00 Average Broker Recommendation 1.5 (Moderate Buy)

PDEX Stock Price Chart Interactive Chart >

Price chart for PDEX

PDEX Price/Volume Stats

Current price $17.61 52-week high $26.50
Prev. close $17.80 52-week low $12.40
Day low $17.10 Volume 3,500
Day high $19.09 Avg. volume 8,163
50-day MA $18.06 Dividend yield N/A
200-day MA $17.12 Market Cap 63.04M

Pro-Dex, Inc. (PDEX) Company Bio

Pro-Dex, Inc. products and distributes medical and dental equipment. The Company offers micro-air motors, surgical drivers, and precision air powered motors. Pro-Dex markets its products in the United States.

PDEX Latest News Stream

Event/Time News Detail
Loading, please wait...

PDEX Latest Social Stream

Loading social stream, please wait...

View Full PDEX Social Stream

Latest PDEX News From Around the Web

Below are the latest news stories about PRO DEX INC that investors may wish to consider to help them evaluate PDEX as an investment opportunity.

Declining Stock and Solid Fundamentals: Is The Market Wrong About Pro-Dex, Inc. (NASDAQ:PDEX)?

With its stock down 11% over the past month, it is easy to disregard Pro-Dex (NASDAQ:PDEX). But if you pay close...

Yahoo | November 23, 2022

Pro-Dex First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags

Pro-Dex ( NASDAQ:PDEX ) First Quarter 2023 Results Key Financial Results Revenue: US$11.1m (up 11% from 1Q 2022). Net...

Yahoo | November 9, 2022

Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results

PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 first quarter ended September 30, 2022.

Yahoo | November 3, 2022

Quite a few insiders invested in Pro-Dex, Inc. (NASDAQ:PDEX) last year which is positive news for shareholders

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | October 22, 2022

Pro-Dex, Inc. Discusses Record-Breaking 4th Quarter Results and Year-Over-Year Growth with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - September 29, 2022) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. CEO of the Company, Rick Van Kirk, joined Stock Day host Everett Jolly.Jolly began the interview by asking about the Company's

Yahoo | September 29, 2022

Read More 'PDEX' Stories Here

PDEX Price Returns

1-mo -6.73%
3-mo -10.38%
6-mo 13.14%
1-year -20.85%
3-year 25.20%
5-year 151.57%
YTD -24.13%
2021 -25.06%
2020 76.47%
2019 45.28%
2018 77.65%
2017 44.68%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7445 seconds.